Zimmer Biomet Archives - Page 7 of 9 - Medical Design Sourcing

Zimmer Biomet dips despite Street-beating Q1

Zimmer Biomet (NYSE:ZBH) shares took a hit today despite first-quarter results that topped the consensus forecast.

The Warsaw, Ind.-based company posted profits of $198.1 million, or 94¢ per share, on sales of more than $1.8 billion for the three months ended March 31, 2021, for a massive bottom-line gain from losses of more than $508 million amid the COVID-19 pandemic a year ago on sales growth of 3.6%.

Adjusted to exclude one-time items, earnings per share were $1.71, 18¢ ahead of Wall Street, where analysts were looking for sales of $1.8 billion.

“Our performance was stronger than we anticipated in the first quarter, as we saw signs of the pandemic beginning to subside across many regions toward the end of the quarter driven by acceleration of vaccine rollout. As we move into the second quarter, we expect that momentum to continue and believe we are well-positioned to meet the needs of our customers as elective procedures return,” Zimmer Biomet…

DeviceTalks Weekly Podcast – iRhythm CEO Mike Coyle, New Podcast!

In this podcast, iRhythm CEO Mike Coyle discusses his decision to join the digital health leader in January.

Coyle’s had to hit the ground running as iRhythm manages some challenging decisions from regional Medicare payors but he also sees great opportunity for the company’s ZIO platform across the healthcare spectrum.

In this conversation, Coyle discusses

How he came to join the Medtech industry. The potential for its ZIO cardiac monitoring technology How the company is dealing with a disappointing reimbursement How the company will pursue the large asymptomatic market What’s expected to come from the company’s partnership with Verily

We also introduce the newest member of our DeviceTalks Podcast family! Catch an excerpt of the first episode in this week’s podcast. Subscribe to hear future episodes.

Caffeine-fueled Chris Newmarker, executive editor of life sciences at Mass Device, takes a break from earnings week to roll out a powerful #newmark…

The 10 largest orthopedic device companies in the world

[Image from Pixaby]Pent-up demand could make orthopedic devices a hot space in 2021.

The COVID-19 pandemic was especially brutal for the orthopedic device industry. Many of the largest companies in the space saw double-digit percentage declines in revenue in 2020. Health providers delayed or canceled elective procedures to focus on the pandemic, and patients stayed away in droves.

It’s a new year now, though, and vaccines are rolling out. People don’t want to live with a bad knee or hip or back forever. Growth will eventually return for the industry, and orthopedic device companies are positioning themselves to be ready.

Rather than hunkering down during the pandemic, many ortho device companies chose shop for new technologies and major M&A deals. They’re reorganizing and launching new products ranging from surgical robots to smart implants.

Read on and discover the latest about the world’s 10 largest orthopedic device companies.

Next>>

FDA clears Zimmer Biomet partial knee system for its Rosa system

Zimmer Biomet today said it received FDA 510(k) clearance for its Rosa Partial Knee system for robotically-assisted partial knee replacement surgeries.

Rosa Partial Knee is the latest addition to Zimmer Biomet’s Rosa Robotics platform, which includes the Rosa Knee system for total knee replacement surgery and Rosa One for neurosurgical and spine procedures. The Rosa Partial Knee is also a part of the company’s ZBEdge.

The partial knee system is designed for compatibility with Zimmer Biomet’s Persona Partial Knee. It has 2D and 3D X-Atlas imaging technology with real-time, intraoperative data collection on soft tissue and bone anatomy to improve bone cut accuracy and range of motion gap analysis.

“The FDA clearance of the Rosa Partial Knee system just two years after the introduction of the Rosa Total Knee system builds on the success of our Rosa robotics portfolio, which is designed to help enhance surgical accuracy, precision and…

9 medical devices you should keep an eye out for in 2021

The medical device industry weathered the COVID-19 pandemic well — and is now set to roll out a host of innovations in 2021.

Economists generally expect the U.S. to see a boom as we emerge from the pandemic and resulting recession. Medtech companies appear set to ride the wave this year, with plans to seek approval or launch a wide range of new products.

Think surgical robotics, smart orthopedic implants, neurostimulation, single-use scopes and much more.

Here are nine devices to especially keep an eye out for this year.

Next>>

DTW Podcast: Earnhardt shares how Abbott shifted gears to counter pandemic; Grail still looks to upend oncology

This week, we’ll talk with Lisa Earnhardt, executive vice president, medical devices at Abbott about how the life sciences giant pivoted during the pandemic.

Earnhardt shares what programs were given greater priority when the impact of the lockdown became clear and why the company performed so well in one of its key businesses.

We also explore this week’s news that the FTC will oppose Illumina’s acquisition of Grail.

First, we talk with Dr. Christopher Keir, vice president of medical affairs at Grail, about the great potential of the company’s diagnostic technologies. The interview was recorded last month prior to the FTC’s decision.

Then we talk to Vijay Kumar, senior managing director at Evercore ISI, about why the FTC is making a strong case to block the deal.

And, of course, Chris …

Zimmer Biomet launches digital and robotic technologies

Zimmer Biomet (NYSE:ZBH) announced today that it launched the ZBEdge connected intelligence suite of digital and robotic technologies.

Warsaw, Ind.-based Zimmer Biomet’s ZBEdge technologies, both currently available and soon to be launched, include the Rosa robotic surgery platform, anatomical visualization and guidance systems such as the Signature One, the iAssist knee alignment system and optical navigation tools.

Additionally, remote care and patient engagement management systems including MyMobility with Apple Watch, along with data services like the OrthoIntel platform and the Omni surgical suite integrated operating room are also included in the ZBEdge portfolio.

Zimmer Biomet’s suite is intended to offer hospitals and ambulatory surgery centers access to pre-, intra- and post-operative technologies, allowing for the use of robotics and digital technologies throughout each patient’s care before aggregating, analyzing and translat…

8 medical device companies that beat the COVID-19 pandemic and prospered

[Image from unsplash.com]Some medical device businesses not only survived the COVID-19 pandemic but actually thrived — with many producing the medtech needed to fight the coronavirus’s spread.

Medical Design & Outsourcing recently analyzed financials for 20 of the largest medical device businesses in the world. Not only was revenue only slightly down for the 20 during 2020, but it was actually up for eight of the 20 companies.

For many of the eight companies that saw sales increase, there was a common theme: They pivoted their focus to the diagnostics imaging and personal protective equipment needed to against COVID-19.

“We had different kinds of companies that were able to benefit on some level from COVID and shutdowns,” Richard Newitter, senior research analyst at SVB Leerink, told MDO.

Overall, medtech sales declined in Q1 and Q2 but then bounced back in a V-shaped recovery for the rest of the year, according to Newitter “It plateaued and actu…

8 medical device companies that beat the COVID-19 pandemic and prospered

[Image from unsplash.com]

Some medical device businesses not only survived the COVID-19 pandemic but actually thrived — with many producing the medtech needed to fight the coronavirus’s spread.

Medical Design & Outsourcing recently analyzed financials for 20 of the largest medical device businesses in the world. Not only was revenue only slightly down for the 20 during 2020, but it was actually up for eight of the 20 companies.

For many of the eight companies that saw sales increase, there was a common theme: They pivoted their focus to the diagnostics imaging and personal protective equipment needed to against COVID-19.

“We had different kinds of companies that were able to benefit on some level from COVID and shutdowns,” Richard Newitter, senior research analyst at SVB Leerink, told MDO.

Overall, medtech sales declined in Q1 and Q2 but then bounced back in a V-shaped recovery fo…

How big medtech fared during a year of COVID-19

[Image from Unsplash]Despite numerous challenges, the medtech industry showed itself to be fairly recession-proof in 2020, according to a Medical Design & Outsourcing/MassDevice analysis of financials.

Annual reports recently released by 20 of the world’s largest medical device companies showed only a slight dip in revenue during 2020 — a year in which medtech held the front lines against the COVID-19 pandemic. Employment was also up slightly amongst the top earners, while R&D spending held its own.

The 20 companies included in the MDO analysis include 3M Healthcare, Abbott (medical device segment), Alcon, Align Technology, Baxter, Boston Scientific, Danaher (life sciences and diagnostics segment), Dentsply Sirona, Edwards Lifesciences, GE Healthcare, Henry Schein, Intuitive Surgical, Johnson & Johnson (medical device segment), Medline Industries, Owens & Minor, Royal Philips, Smith+Nephew, Stryker, Teleflex and Zimmer Biomet.

Get the full s…

How big medtech fared during a year of COVID-19

[Photo from Unsplash]

Despite numerous challenges, the medtech industry showed itself to be fairly recession-proof in 2020, according to a Medical Design & Outsourcing analysis of financials.

Annual reports recently released by 20 of the world’s largest medical device companies showed only a slight dip in revenue during 2020 — a year in which medtech held the front lines against the COVID-19 pandemic. Employment was also up slightly amongst the top earners, while R&D spending held its own.

The 20 companies included in the MDO analysis include 3M Healthcare, Abbott (medical device segment), Alcon, Align Technology, Baxter, Boston Scientific, Danaher (life sciences and diagnostics segment), Dentsply Sirona, Edwards Lifesciences, GE Healthcare, Henry Schein, Intuitive Surgical, Johnson & Johnson (medical device segment), Medline Industries, Owens & Minor, Royal Philips, Smith+Nephew, …

Zimmer Biomet names chief operating officer

Zimmer Biomet (NYSE:ZBH) today said it has appointed Ivan Tornos to the newly-created role of chief operating officer.

Tornos previously served as group president of orthopedics and was later appointed group president of global businesses and the Americas.

As chief operating officer, Tornos will be responsible for overseeing all global businesses at Zimmer Biomet, as well as leading global operations, clinical and medical education and global R&D and new product development functions. He will also be responsible for oversight of the Europe, Middle East and Africa region with the president of EMEA reporting to him. Tornos will report to president and CEO Bryan Hanson.

“Since joining Zimmer Biomet, Ivan has made tremendous contributions toward the strategic evolution of our business, delivering consistent results across the board,” Hanson said in a news release. “As we continue to transform the company, having Ivan at the helm in this…